After completing this activity, pharmacists should be able to:
- describe the physiological regulation and role of melatonin in humans;
- describe how medications can interfere with melatonin synthesis and metabolism;
- explain the pharmacotherapeutic impact of exogenous melatonin;
- describe how melatonin can affect circadian rhythm physiology.
The 2016 Competency Standards addressed by this activity include: 1.3, 3.2, 3.5, 3.6
Accreditation number: A2011AJP2 Accreditation expires: 01/11/2022
This activity has been accredited for 1.5 hours of Group One CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.5 hours of Group Two CPD (or 3.0 CPD credits) upon successful completion of the associated assessment activity.